Showing results (61-70 of 167) with videos related to
Sort By:
Pageof 17
Ethnicity & Disease|March 28, 2013
The impact of diabetes on ethnic disparities seen in kidney transplantationDavid J Taber, Holly B Meadows, Nicole A Pilch, et al.Pharmacotherapy|November 21, 2012
Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomesDavid J Taber, Nicole A Pilch, Charles F Bratton, et al.American Journal of Surgery|June 23, 2021
The impact of race on metabolic, graft, and patient outcomes after pancreas transplantationHaley M Gonzales, David J Taber, Satish Nadig, et al.JMIR Research Protocols|October 2, 2019
Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled TrialCasey L Hall, Cory E Fominaya, Mulugeta Gebregziabher, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 1, 2024
Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantationKarim Soliman, Isabel K Calimlim, Amy Perry, et al.Clinical Transplantation|August 18, 2019
Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modalityVinayak S Rohan, John W McGillicuddy, David J Taber, et al.Journal of the American Pharmacists Association : Japha|February 9, 2020
The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patternsJames N Fleming, Jingwen Zhang, David J Taber, et al.Progress in Transplantation (Aliso Viejo, Calif.)|April 12, 2023
A Randomized Control Trial Testing a Medication Safety Dashboard in Veteran Transplant RecipientsDavid J Taber, Sherry Milfred-LaForest, Kelsey Rife, et al.Primary Care Diabetes|April 30, 2023
Sulfonylureas as second line therapy for type 2 diabetes among veterans: Results from a National Longitudinal Cohort StudyErin R Weeda, Ralph Ward, Mulugeta Gebregziabher, et al.Pharmacotherapy|May 27, 2015
African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipientsDavid J Taber, Mulugeta G Gebregziabher, Titte R Srinivas, et al.Pageof 17